Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) have received a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $31.3750.
BTSG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft set a $30.00 price objective on BrightSpring Health Services and gave the company a “buy” rating in a research note on Monday, September 8th. Bank of America boosted their price objective on BrightSpring Health Services from $27.50 to $31.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of BrightSpring Health Services in a research note on Wednesday, October 8th. Wall Street Zen downgraded BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 26th. Finally, UBS Group boosted their price objective on BrightSpring Health Services from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Monday.
Read Our Latest Research Report on BrightSpring Health Services
Institutional Trading of BrightSpring Health Services
BrightSpring Health Services Stock Down 4.2%
Shares of NASDAQ:BTSG opened at $29.45 on Friday. The company has a market capitalization of $5.22 billion, a price-to-earnings ratio of 95.00, a P/E/G ratio of 0.51 and a beta of 2.40. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.76 and a quick ratio of 1.34. The business’s 50-day moving average is $26.07 and its 200-day moving average is $22.58. BrightSpring Health Services has a 1 year low of $14.73 and a 1 year high of $31.95.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $3.15 billion for the quarter, compared to the consensus estimate of $2.99 billion. BrightSpring Health Services had a return on equity of 9.29% and a net margin of 0.55%.The firm’s revenue was up 15.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.10 EPS. BrightSpring Health Services has set its FY 2025 guidance at EPS. Equities research analysts predict that BrightSpring Health Services will post 0.59 earnings per share for the current year.
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Read More
- Five stocks we like better than BrightSpring Health Services
- Should You Invest in Penny Stocks?
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- CD Calculator: Certificate of Deposit Calculator
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- Conference Calls and Individual Investors
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.